Renal Cell Carcinoma
Showing NaN - NaN of 45
Metastatic Solid Tumors, NSCLC, Melanoma Trial in United States (INBRX-105 - PDL1x41BB antibody, Pembrolizumab)
Recruiting
- Metastatic Solid Tumors
- +7 more
- INBRX-105 - PDL1x41BB antibody
- Pembrolizumab
-
Scottsdale, Arizona
- +12 more
Jan 26, 2023
Advanced Solid Tumor, Castration-Resistant Prostatic Cancer, Malignant Melanoma Trial in United States (MGC018, lorigerlimab)
Recruiting
- Advanced Solid Tumor
- +6 more
- vobramitamab duocarmazine
- lorigerlimab
-
Los Angeles, California
- +7 more
Jan 10, 2023
Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)
Completed
- Melanoma
- +27 more
- XmAb20717
-
Los Angeles, California
- +16 more
Nov 29, 2022
Melanoma, Prostate Cancer, Ovarian Cancer Trial in United States (Pegilodecakin, Paclitaxel or Docetaxel and Carboplatin or
Active, not recruiting
- Melanoma
- +8 more
- Pegilodecakin
- +9 more
-
Los Angeles, California
- +9 more
Nov 15, 2022
Renal Cell Carcinoma Trial in United States (Nivolumab, Ipilimumab)
Completed
- Renal Cell Carcinoma
-
Muscle Shoals, Alabama
- +60 more
Oct 6, 2022
Non-small-cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma Trial in United States
Active, not recruiting
- Non-small-cell Lung Cancer
- +5 more
- PF-07209960
-
Duarte, California
- +11 more
Oct 10, 2022
Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)
Recruiting
- Solid Tumor
- +11 more
- TRK-950
- +14 more
-
Scottsdale, Arizona
- +13 more
Oct 2, 2022
Study of Kidney Tumors in Younger Patients
Recruiting
- Adult Cystic Nephroma
- +24 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +247 more
Sep 2, 2022
Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus
Recruiting
- Mesothelioma
- +14 more
- NGM707
- NGM707 plus pembrolizumab
-
Los Angeles, California
- +13 more
Aug 16, 2022
Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)
Completed
- Melanoma
- +6 more
- Combination of NKTR-214 + nivolumab
-
La Jolla, California
- +57 more
Jun 22, 2022
Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)
Recruiting
- Pancreatic Cancer
- +15 more
- NGM831
- NGM831 plus pembrolizumab
-
Gilbert, Arizona
- +4 more
Jun 21, 2022
Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,
Active, not recruiting
- Adrenal Cortex Carcinoma
- +39 more
- Cabozantinib
- +2 more
-
Birmingham, Alabama
- +142 more
May 24, 2022
NSCLC, Small Cell Lung Cancer, Urothelial Carcinoma Trial in United States (N-803 + Pembrolizumab, N-803 + Nivolumab, N-803 +
Active, not recruiting
- Non-Small Cell Lung Cancer
- +12 more
- N-803 + Pembrolizumab
- +9 more
-
Anchorage, Alaska
- +34 more
Apr 4, 2022
Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (bempegaldesleukin, sunitinib, nivolumab)
Active, not recruiting
- Renal Cell Carcinoma
- Metastatic Renal Cell Carcinoma
- bempegaldesleukin
- +3 more
-
Anchorage, Alaska
- +108 more
Mar 31, 2022
Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)
Completed
- Advanced Solid Tumors
- +6 more
- Cabiralizumab
- Nivolumab
-
Scottsdale, Arizona
- +38 more
Jan 5, 2022
Renal Cell Carcinoma Trial in United States (Entinostat, Interleukin-2)
Active, not recruiting
- Renal Cell Carcinoma
-
Los Angeles, California
- +4 more
Feb 14, 2022
Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)
Completed
- Prostate Cancer
- +6 more
- MGA271
-
Los Angeles, California
- +11 more
Feb 4, 2022
